1.9000
+0.0100
+(0.53%)
At close: 4:00:02 PM EDT
1.8900
-0.01
(-0.53%)
After hours: 4:28:54 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 1,390,800 | 6 |
| Sales | 334,132 | 6 |
| Net Shares Purchased (Sold) | 1,056,668 | 12 |
| Total Insider Shares Held | 9.94M | -- |
| % Net Shares Purchased (Sold) | 11.90% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| BURKE STEVEN KEITH Officer | Sale at price 1.83 per share. | Direct | 13,074 | Mar 3, 2025 |
| BUTLER JOHN P Chief Executive Officer | Sale at price 1.83 per share. | Direct | 84,928 | Mar 3, 2025 |
| BURKE STEVEN KEITH Officer | Sale at price 2.10 per share. | Direct | 106,063 | Feb 3, 2025 |
| BUTLER JOHN P Chief Executive Officer | Sale at price 2.10 per share. | Direct | 302,925 | Feb 3, 2025 |
| GRUND NICHOLAS Officer | Sale at price 2.10 per share. | Direct | 116,804 | Feb 3, 2025 |
| MALABRE RICHARD C. Officer | Sale at price 2.10 per share. | Direct | 63,424 | Feb 3, 2025 |
| BURKE STEVEN KEITH Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| BUTLER JOHN P Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| GRUND NICHOLAS Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| OSTROWSKI ERIK Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| MALABRE RICHARD C. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| FRIESON RON Director | Conversion of Exercise of derivative security at price 0.45 per share. | Direct | 9,045 | Jan 17, 2025 |
| OSTROWSKI ERIK Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 28, 2024 |
| ZUMWALT LEANNE M Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
| SMITH CYNTHIA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
| ROGERS MICHAEL W Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
| ADAMS ADRIAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
| GILMAN STEVEN C Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
| WOLF MYLES Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
| FRIESON RON Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
| HADAS NICOLE R Officer | Sale at price 1.26 per share. | Direct | 15,140 | May 13, 2024 |
| DAHAN MICHEL Chief Operating Officer | Sale at price 1.26 per share. | Direct | 43,898 | May 13, 2024 |
| BURKE STEVEN KEITH Officer | Sale at price 1.58 per share. | Direct | 11,327 | Feb 29, 2024 |
| BUTLER JOHN P Chief Executive Officer | Sale at price 1.58 per share. | Direct | 73,581 | Feb 29, 2024 |
| HADAS NICOLE R Officer | Sale at price 1.58 per share. | Direct | 9,439 | Feb 29, 2024 |
| DAHAN MICHEL Chief Operating Officer | Sale at price 1.58 per share. | Direct | 13,684 | Feb 29, 2024 |
| BURKE STEVEN KEITH Officer | Sale at price 1.52 per share. | Direct | 12,718 | Feb 27, 2024 |
| BUTLER JOHN P Chief Executive Officer | Sale at price 1.52 per share. | Direct | 57,354 | Feb 27, 2024 |
| HADAS NICOLE R Officer | Sale at price 1.52 per share. | Direct | 11,265 | Feb 27, 2024 |
| DAHAN MICHEL Chief Operating Officer | Sale at price 1.52 per share. | Direct | 16,331 | Feb 27, 2024 |
| BURKE STEVEN KEITH Officer | Sale at price 1.68 per share. | Direct | 40,842 | Feb 1, 2024 |
| BUTLER JOHN P Chief Executive Officer | Sale at price 1.68 per share. | Direct | 78,102 | Feb 1, 2024 |
| BURKE STEVEN KEITH Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2024 |
| BUTLER JOHN P Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2024 |
| HADAS NICOLE R Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2024 |
| GRUND NICHOLAS Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2024 |
| DAHAN MICHEL Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2024 |
| SNOW ELLEN Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2024 |
| MALABRE RICHARD C. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2024 |
| BURKE STEVEN KEITH Officer | Sale at price 1.15 per share. | Direct | 31,050 | Aug 25, 2023 |
| SNOW ELLEN Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 31, 2023 |
| ZUMWALT LEANNE M Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2023 |
| SMITH CYNTHIA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2023 |
| ROGERS MICHAEL W Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2023 |
| ADAMS ADRIAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2023 |
| GILMAN STEVEN C Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2023 |
| SMITH CYNTHIA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2023 |
| WOLF MYLES Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2023 |
| FRIESON RON Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2023 |
| HADAS NICOLE R Officer | Sale at price 1.22 per share. | Direct | 77,270 | May 25, 2023 |
Related Tickers
ESPR Esperion Therapeutics, Inc.
0.9639
-3.19%
AQST Aquestive Therapeutics, Inc.
2.5000
-2.72%
BCRX BioCryst Pharmaceuticals, Inc.
7.22
-2.43%
AVDL Avadel Pharmaceuticals plc
8.15
+3.03%
IRWD Ironwood Pharmaceuticals, Inc.
0.7500
+3.85%
SCYX SCYNEXIS, Inc.
0.9126
-0.39%
DVAX Dynavax Technologies Corporation
10.65
-6.66%
AYTU Aytu BioPharma, Inc.
1.0200
-0.97%
RGC Regencell Bioscience Holdings Limited
27.25
-16.44%
EBS Emergent BioSolutions Inc.
4.6200
-0.22%